[go: up one dir, main page]

DE69031225D1 - Monoklonaler antikörper zur differenzierung von "squamous cell carcinoma"-antigenen und verfahren zu dessen verwendung - Google Patents

Monoklonaler antikörper zur differenzierung von "squamous cell carcinoma"-antigenen und verfahren zu dessen verwendung

Info

Publication number
DE69031225D1
DE69031225D1 DE69031225T DE69031225T DE69031225D1 DE 69031225 D1 DE69031225 D1 DE 69031225D1 DE 69031225 T DE69031225 T DE 69031225T DE 69031225 T DE69031225 T DE 69031225T DE 69031225 D1 DE69031225 D1 DE 69031225D1
Authority
DE
Germany
Prior art keywords
cell carcinoma
squamous cell
antigens
mab
differentiating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69031225T
Other languages
English (en)
Other versions
DE69031225T2 (de
Inventor
John Samuel
Bryan Michael Longenecker
Grazyna Stanczyk-Brzezinska
David Willans
Louis H Honore
Deborah M Haines
Erwin Diener
Lei Ding
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncothyreon Canada Inc
Original Assignee
Biomira Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomira Inc filed Critical Biomira Inc
Publication of DE69031225D1 publication Critical patent/DE69031225D1/de
Application granted granted Critical
Publication of DE69031225T2 publication Critical patent/DE69031225T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69031225T 1989-04-21 1990-04-20 Monoklonaler antikörper zur differenzierung von "squamous cell carcinoma"-antigenen und verfahren zu dessen verwendung Expired - Fee Related DE69031225T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34140289A 1989-04-21 1989-04-21
PCT/US1990/002152 WO1990012885A1 (en) 1989-04-21 1990-04-20 Monoclonal antibody for differentiation of squamous cell carcinoma antigens and method of use for same

Publications (2)

Publication Number Publication Date
DE69031225D1 true DE69031225D1 (de) 1997-09-11
DE69031225T2 DE69031225T2 (de) 1997-12-11

Family

ID=23337398

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69031225T Expired - Fee Related DE69031225T2 (de) 1989-04-21 1990-04-20 Monoklonaler antikörper zur differenzierung von "squamous cell carcinoma"-antigenen und verfahren zu dessen verwendung

Country Status (8)

Country Link
EP (1) EP0548070B1 (de)
JP (1) JP2919961B2 (de)
AT (1) ATE156521T1 (de)
AU (1) AU649613B2 (de)
CA (1) CA1340245C (de)
DE (1) DE69031225T2 (de)
FI (1) FI914924A7 (de)
WO (1) WO1990012885A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858683A (en) * 1996-08-30 1999-01-12 Matritech, Inc. Methods and compositions for the detection of cervical cancer
US7361336B1 (en) 1997-09-18 2008-04-22 Ivan Bergstein Methods of cancer therapy targeted against a cancer stem line
IL144933A0 (en) * 1999-02-23 2002-06-30 Oralscan Lab Inc Minimally invasive apparatus and method for testing lesions of the oral cavity and similar epithelium

Also Published As

Publication number Publication date
WO1990012885A1 (en) 1990-11-01
DE69031225T2 (de) 1997-12-11
ATE156521T1 (de) 1997-08-15
AU649613B2 (en) 1994-06-02
JPH05504465A (ja) 1993-07-15
FI914924A0 (fi) 1991-10-18
JP2919961B2 (ja) 1999-07-19
FI914924A7 (fi) 1991-10-18
EP0548070B1 (de) 1997-08-06
CA1340245C (en) 1998-12-15
AU5659190A (en) 1990-11-16
EP0548070A1 (de) 1993-06-30

Similar Documents

Publication Publication Date Title
NZ232554A (en) 100,000 dalton tumour cell glycoprotein antigen (l45), monoclonal antibodies thereto and medicaments
IL135775A0 (en) Antibodies and immunoconjugates having high binding affinity for mesothelin
NZ331978A (en) Monoclonal antibody to CEA (carcinomembryonic antigen), conjugates comprising said antibody, and their therapeutic use in an adept system
IL140138A (en) Specific antibodies of tie-2 ligands
DK1180123T3 (da) Immunkonjugater, der har höj bindingsaffinitet
KR920700692A (ko) 사람의 종양과 연합한 신규 항원에 대한 신규의 일클론 항체
DE69429092D1 (de) Verfahren zur kontrolle von b-zellenpopulation
MD1374G2 (ro) Anticorpi monoclonali imunostimulatori, procedeu de obţinere a acestora, linii celulare, metodă de tratare a maladiilor şi compoziţie farmaceutică
NZ210867A (en) Tumour-specific monoclonal antibodies, production thereof and use
ATE233102T1 (de) Verfahren und zusammensetzung zur umgestaltung multi-epitopischer antigene um die immunantwort einzuleiten
NZ219338A (en) Monoclonal antibody to non-small cell lung carcinoma, its use, production and antigen
DE69031225D1 (de) Monoklonaler antikörper zur differenzierung von "squamous cell carcinoma"-antigenen und verfahren zu dessen verwendung
ES557680A0 (es) Un metodo de detecion y diagnostico de cancer empleando un nuevo antigeno asociado a un tumor.
EP0537168A4 (en) Ctaa 28a32, the antigen recognized by mca 28a32
DE3784364D1 (de) Tumorassoziiertes antigen.
EP0243058A3 (en) A novel tumor associated antigen
Colapinto et al. The Applications of Monoclonal Antibodies in Neuro-Oncology

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee